VahatiCor
PrivateLast Round
Series B
Nov 18, 2025
Est. Valuation
$48M
Total Funding Raised
$23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VahatiCor is a medical technology company developing the A-FLUX Reducer System, an implantable device designed to treat Coronary Microvascular Dysfunction (CMD).
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VahatiCor Comparables
Compare VahatiCor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Advanced NanoTherapies | 30% |
VahatiCor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 18, 2025 |
VahatiCor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| T45 Labs | Series B |
| Intuitive Ventures | Series B |
| S3 Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 34% MoM, reaching 1.7K.
- Jul 22, 2026
Grew 27% QoQ, from 15 to 19 employees.
VahatiCor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VahatiCor's valuation, stock price, and market status.
Is VahatiCor a public or private company?
VahatiCor is a private company.
What is the current stock price of VahatiCor?
VahatiCor is a private company, so its shares have no public market price. Caplight tracks VahatiCor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VahatiCor worth (valuation)?
VahatiCor's valuation is estimated at $48.0M based on funding round data.
Can I buy VahatiCor stock?
VahatiCor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VahatiCor's last funding round?
VahatiCor's most recent funding round was Series B on November 18, 2025.
Who are the main investors in VahatiCor?
Key investors in VahatiCor include S3 Ventures.
Will VahatiCor IPO soon?
No public IPO plans have been announced for VahatiCor.
How can I track VahatiCor secondary market activity?
Caplight tracks bids, offers, and trades in VahatiCor's shares on secondary markets.